MMP Capital, a lender specializing in equipment financing, leasing and unsecured capital financing, originated more than $20 million in financing in July, following a company-record-breaking Q2/21 for the company in which it originated $50 million in financing, representing a 21% year-to-date increase compared with 2019.

“Over the past eight years, MMP Capital has developed a reputation as the gold standard of aesthetic medical financing. Key lending partners and manufacturers are increasingly approaching us to partner with MMP Capital for long-term success and profitability,” John-Paul Smolenski, president and CEO of MMP Capital, said. “Our streamlined approach to healthcare financing is a key differentiator for MMP Capital in a crowded market of smaller, less reputable companies who do not have the proper industry experience to truly understand what the customer wants, why they are purchasing it and how it will help their business.”